Pet nutrition is where animal health innovation is moving fastest. Novel proteins, botanical extracts, postbiotics, calming and joint supplements, functional ingredients promising benefits far beyond basic nutrition are what pet owners are demanding, retailers are stocking them, and investors are funding the brands that make them.

But between a promising ingredient and a product on the shelf stands a question every serious brand must answer with data: Is it safe for your pet to consume the food ingredient every day over the course of several years?

An ingredient with decades of feeding history carries its own evidence. A novel ingredient carries none. The FDA Center for Veterinary Medicine regulates food for animals just as it regulates drugs, and every recognized pathway for a new ingredient. A food additive petition, a GRAS conclusion or an ingredient definition rests on the same foundation: scientific evidence of safety at the intended level of use, in the intended species. For substances fed daily to pets, well-designed in vivo studies are what make a dossier persuasive to regulators and to retail partners running due diligence. Here are the nonclinical studies that build that evidence.

Target Animal Safety and Tolerance Studies

The anchor of any ingredient dossier. The question is direct: what happens when the target species consumes the ingredient at, and at multiples of the intended inclusion level? Tolerance studies feed the ingredient at exaggerated levels over weeks to months, with endpoints including body weight, food consumption, clinical observations, clinical pathology, and, where warranted, histopathology. This is the same target animal safety discipline required for veterinary drugs, applied to a dietary matrix and it establishes the margin of safety on which everything else in the submission stands.

Toxicology for Concentrated Actives

Supplements and functional ingredients frequently deliver a concentrated bioactive rather than a bulk nutrient, and for these the program resembles conventional toxicology: dose-setting relative to the recommended serving, repeat-dose designs of appropriate duration, recovery phases, and full clinical and anatomic pathology. Where the active has systemic exposure, pharmacokinetic characterization strengthens the dossier further by tying safety findings to measured internal exposure.

Study Design: Where Ingredient Programs Are Won or Lost

Dietary studies have their own craft. Dosing runs by dietary inclusion or per-serving administration rather than simple gavage, so diet formulation, ingredient stability in feed, and verified intake become study-critical variables. Duration should mirror real-world exposure: a daily-use supplement justifies a longer window than an occasional treat. And because the “dose” is delivered through a food the animal must willingly consume, therefore safety endpoints need to be part of one integrated plan from the outset, not a series of afterthoughts that leaves retailers or regulators to identify gaps later.

Why Choose Attentive Science

If you are developing a novel protein, botanical, supplement, or functional ingredient, the safety program you run now determines how smoothly everything downstream goes. Ingredient safety isn't a checkbox. It's a commitment to the animals who eat what you make, to the owners who trust your label, and to the healthier outcomes both deserve.

At Attentive Science, we specialize in delivering GLP-compliant nonclinical studies that carry novel pet food ingredients from concept to confident launch. Our facility is AAALAC International accredited, and our GLP compliance has been tested where it counts.

Our commitment ensures that every study whether target animal safety or toxicology is guided by scientific rigor, transparent processes, meticulous documentation, and an unwavering focus on data integrity and regulatory expectations. Contact Us